2017 Executive Sponsors
2017 Associate Sponsors
2017 Supporting Sponsor
2017 Lead Media Partner
2017 Supporting Partner
2017 Media Partners
The Clinical Trial Collaborations (CTC) conference focused on arguably the most important change in drug development: How we are altering the way we collaborate to drive greater efficiencies in productivity and bring us closer to the patient.
At the 2nd annual CTC event, we presented a wide variety of sessions, which demonstrated new ways of collaborating for improved clinical trial outcomes as well as addressing how to strike a better balance in the delivery model for effective drug development.
We were pleased to announce that the 2017 conference opened with Ken Getz, Director of Sponsored Research Programs, Tufts CSDD, on how the Clinical Collaborations Landscape is Changing and its Impact on R&D Operations.
Immediately following this session was a fireside keynote discussion with Dr Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck, who joined Ken in an honest and open discussion on Models for Exquisite Project Delivery with Internal and External Partners.
Another keynote was Dr Andy Plump, Chief Medical & Scientific Officer, Takeda and Dr Steve Cutler, CEO, ICON. We were delighted to welcome back Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly, as Chair. New to the program Katherine Capparella and Bennett Levitan, provided a case study on how Janssen is creating strategic collaborations that are driving patient centered trials.
2017 Keynotes to Date
Clinical Research as a Care Option
We were particularly excited to present a collaborative session on Clinical Research as a Care Option. This section of the 2017 CTC event made up 25% of the program and for good reason. If we really want to bring patients closer to clinical research, we have to figure out how to collaborate to make clinical trials a care option. Higher rates of clinical trial participation inside a health system produces better patient outcomes, lower cost of care and happier patients. Health systems and patients get access to the latest research and pharma gets access to more patients. This is why we dedicated the entire afternoon of April 4 to working through the process of how to make this a reality.
New to the 2017 Conference: Partnering Tool
Also new to the 2017 event was access to a partnering tool and partnering facilities to have small group and one-on-one meetings.
CTC presented insightful ideas and challenges for R&D operations, CROs and site executives to discover new ways of collaborating. The conference is designed for senior level clinical operation executives from large, medium and small pharmas, CROs and sites. Patient advocacy organizations are also encouraged to attend.
"Topics were well defined and the presenters focused in on topics without meandering into other areas of discussion."
- Joshua Fama, ISDM Solutions LLC
"I enjoyed the keynote speakers and the group panels."
- Jamie Kime, UCB